Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Lepperhof, Vera ^a   Polchynski, Olga ^a   Kruttwig, Klaus ^b   Brüggemann, Chantal ^b   Neef, Klaus ^a   Drey, Florian ^a   Zheng, Yunjie ^a   Ackermann, Justus P ^b   Choi, Yeong Hoon ^a   Wunderlich, Thomas F ^a,b,c   Hoehn, Mathias ^b   Hescheler, Jürgen ^a   Šarić, Tomo ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ENHANCED GREEN FLUORESCENT PROTEIN; FIREFLY LUCIFERASE; PUROMYCIN; ZINC FINGER NUCLEASE; GT(ROSA)26SOR NON-CODING RNA, MOUSE; UNTRANSLATED RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL KINETICS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA INTEGRATION; GENE; GENE CASSETTE; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENOME ANALYSIS; GRAFT RECIPIENT; HEART INFARCTION; HEART MUSCLE CELL; IMMUNOHISTOLOGY; IN VIVO STUDY; LONG TERM SURVIVAL; LUCIFERASE ASSAY; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; ROSA26 GENE; SCAR FORMATION; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; CELL LINE; CYTOLOGY; GENETIC TRANSDUCTION; GENETICS; LUMINESCENCE; MALE; METABOLISM; MORTALITY; MYOCARDIAL INFARCTION; PATHOLOGY; PROCEDURES; PROMOTER REGION; REPORTER GENE; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; GENE SILENCING; GENES, REPORTER; GENETIC LOCI; INDUCED PLURIPOTENT STEM CELLS; LUMINESCENT MEASUREMENTS; MALE; MICE; MOLECULAR IMAGING; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; RNA, UNTRANSLATED; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84907185296     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107363     Document Type: Article

References (74)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220.
2. Burt RK, Chen YH, Verda L, Lucena C, Navale S, et al. (2012) Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: a preclinical study. Circ Res 111: 1286-1296.
3. Singla DK, Lyons GE, Kamp TJ (2007) Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293: H1308-1314.
4. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, et al. (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120: 408-416.
5. Yan B, Abdelli LS, Singla DK (2011) Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice. Mol Pharm 8: 1602-1610.
6. Liu Y, Ye X, Mao L, Cheng Z, Yao X, et al. (2013) Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction. Cardiovasc Res 97: 208-218.
7. Ahmed RP, Haider HK, Buccini S, Li L, Jiang S, et al. (2011) Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. Circ Res 109: 60-70.
8. Caspi O, Huber I, Kehat I, Habib M, Arbel G, et al. (2007) Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50: 1884-1893.
9. Didie M, Christalla P, Rubart M, Muppala V, Doker S, et al. (2013) Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest 123: 1285-1298.
10. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, et al. (2006) Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 203: 2315-2327.
11. Miki K, Uenaka H, Saito A, Miyagawa S, Sakaguchi T, et al. (2012) Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med 1: 430-437.
12. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, et al. (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489: 322-325.
13. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, et al. (2012) Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59: 942-953.
14. Matsuura K, Honda A, Nagai T, Fukushima N, Iwanaga K, et al. (2009) Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119: 2204-2217.
15. Assmus B, Rolf A, Erbs S, Elsasser A, Haberbosch W, et al. (2010) Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 3: 89-96.
16. van der Bogt KE, Sheikh AY, Schrepfer S, Hoyt G, Cao F, et al. (2008) Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118: S121-129.
17. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, et al. (2004) Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22: 1282-1289.
18. Gupta MK, Illich DJ, Gaarz A, Matzkies M, Nguemo F, et al. (2010) Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 10: 98.
19. Gherghiceanu M, Barad L, Novak A, Reiter I, Itskovitz-Eldor J, et al. (2011) Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure. J Cell Mol Med 15: 2539-2551.
20. Kuzmenkin A, Liang H, Xu G, Pfannkuche K, Eichhorn H, et al. (2009) Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J 23: 4168-4180.
21. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, et al. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-41.
22. Boheler KR, Joodi RN, Qiao H, Juhasz O, Urick AL, et al. (2011) Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration. Stem Cells Int 2011: 214203.
23. Cao F, Wagner RA, Wilson KD, Xie X, Fu JD, et al. (2008) Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One 3: e3474.
24. Li Z, Lee A, Huang M, Chun H, Chung J, et al. (2009) Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol 53: 1229-1240.
25. Terrovitis JV, Smith RR, Marban E (2010) Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 106: 479-494.
26. Wu JC, Chen IY, Sundaresan G, Min JJ, De A, et al. (2003) Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108: 1302-1305.
27. Wu KH, Mo XM, Han ZC, Zhou B (2011) Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg 92: 1917-1925.
28. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, et al. (2002) Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34: 107-116.
29. Zhang WY, Ebert AD, Narula J, Wu JC (2011) Imaging cardiac stem cell therapy: translations to human clinical studies. J Cardiovasc Transl Res 4: 514-522.
30. de Almeida PE, van Rappard JR, Wu JC (2011) In vivo bioluminescence for tracking cell fate and function. Am J Physiol Heart Circ Physiol 301: H663-671.
31. Kammili RK, Taylor DG, Xia J, Osuala K, Thompson K, et al. (2010) Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo. Stem Cells Dev 19: 1437-1448.
32. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11: 636-646.
33. Mao X, Fujiwara Y, Orkin SH (1999) Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci U S A 96: 5037-5042.
34. Meissner A, Wernig M, Jaenisch R (2007) Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25: 1177-1181.
35. Perez-Pinera P, Ousterout DG, Brown MT, Gersbach CA (2012) Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res 40: 3741-3752.
36. Chen X, Prywes R (1999) Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression. Mol Cell Biol 19: 4695-4702.
37. Chen CM, Krohn J, Bhattacharya S, Davies B (2011) A comparison of exogenous promoter activity at the ROSA26 locus using a PhiiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One 6: e23376.
38. Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, et al. (1997) Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci U S A 94: 3789-3794.
39. Chang C, Chan A, Lin X, Higuchi T, Terrovitis J, et al. (2013) Cellular bioenergetics is an important determinant of the molecular imaging signal derived from luciferase and the sodium-iodide symporter. Circ Res 112: 441-450.
40. Bai X, Yan Y, Coleman M, Wu G, Rabinovich B, et al. (2011) Tracking longterm survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging. Mol Imaging Biol 13: 633-645.
41. Sheikh AY, Huber BC, Narsinh KH, Spin JM, van der Bogt K, et al. (2012) In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium. Arterioscler Thromb Vasc Biol 32: 92-102.
42. Min JJ, Ahn Y, Moon S, Kim YS, Park JE, et al. (2006) In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium. Ann Nucl Med 20: 165-170.
43. Swijnenburg RJ, Govaert JA, van der Bogt KE, Pearl JI, Huang M, et al. (2010) Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction. Circ Cardiovasc Imaging 3: 77-85.
44. Westrich J, Yaeger P, He C, Stewart J, Chen R, et al. (2010) Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium. Cell Transplant 19: 937-948.
45. Li SH, Lai TY, Sun Z, Han M, Moriyama E, et al. (2009) Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intraaortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 137: 1225-1233 e1221.
46. Sheikh AY, Lin SA, Cao F, Cao Y, van der Bogt KE, et al. (2007) Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells 25: 2677-2684.
47. Kutschka I, Chen IY, Kofidis T, Arai T, von Degenfeld G, et al. (2006) Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 114: I167-173.
48. Rodriguez-Porcel M, Gheysens O, Paulmurugan R, Chen IY, Peterson KM, et al. (2010) Antioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium. Mol Imaging Biol 12: 325-334.
49. Lan F, Liu J, Narsinh KH, Hu S, Han L, et al. (2012) Safe genetic modification of cardiac stem cells using a site-specific integration technique. Circulation 126: S20-28.
50. Hu S, Huang M, Nguyen PK, Gong Y, Li Z, et al. (2011) Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation 124: S27-34.
51. Mohsin S, Khan M, Toko H, Bailey B, Cottage CT, et al. (2012) Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol 60: 1278-1287.
52. Xie X, Cao F, Sheikh AY, Li Z, Connolly AJ, et al. (2007) Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning Stem Cells 9: 549-563.
53. Lee AS, Tang C, Cao F, Xie X, van der Bogt K, et al. (2009) Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8: 2608-2612.
54. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, et al. (2007) Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116: I46-54.
55. Wang Y, Zhang WY, Hu S, Lan F, Lee AS, et al. (2012) Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging. Circ Res 111: 1494-1503.
56. Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, et al. (2012) Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 20: 1014-1021.
57. Macarthur CC, Xue H, Van Hoof D, Lieu PT, Dudas M, et al. (2012) Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev 21: 191-205.
58. Pfaff N, Lachmann N, Ackermann M, Kohlscheen S, Brendel C, et al. (2013) A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 31: 488-499.
59. Krishnan M, Park JM, Cao F, Wang D, Paulmurugan R, et al. (2006) Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J 20: 106-108.
60. He J, Yang Q, Chang LJ (2005) Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells. J Virol 79: 13497-13508.
61. Hino S, Fan J, Taguwa S, Akasaka K, Matsuoka M (2004) Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure. Gene Ther 11: 819-828.
62. Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, et al. (2009) Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 27: 851-857.
63. Ding Q, Lee YK, Schaefer EA, Peters DT, Veres A, et al. (2013) A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 12: 238-251.
64. Pfannkuche K, Liang H, Hannes T, Xi J, Fatima A, et al. (2009) Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell Physiol Biochem 24: 73-86.
65. Wu JC, Cao F, Dutta S, Xie X, Kim E, et al. (2006) Proteomic analysis of reporter genes for molecular imaging of transplanted embryonic stem cells. Proteomics 6: 6234-6249.
66. Wu JC, Spin JM, Cao F, Lin S, Xie X, et al. (2006) Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol Genomics 25: 29-38.
67. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, et al. (2009) Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 87: 642-652.
68. Pfannkuche K, Neuss S, Pillekamp F, Frenzel LP, Attia W, et al. (2010) Fibroblasts facilitate the engraftment of embryonic stem cell-derived cardiomyocytes on three-dimensional collagen matrices and aggregation in hanging drops. Stem Cells Dev 19: 1589-1599.
69. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25: 1015-1024.
70. Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, et al. (2005) Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167: 663-671.
71. Haider H, Ashraf M (2008) Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45: 554-566.
72. Sekine H, Shimizu T, Dobashi I, Matsuura K, Hagiwara N, et al. (2011) Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A 17: 2973-2980.
73. Kearns-Jonker M, Dai W, Gunthart M, Fuentes T, Yeh HY, et al. (2012) Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart. J Stem Cell Res Ther S1.
74. Templin C, Zweigerdt R, Schwanke K, Olmer R, Ghadri JR, et al. (2012) Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation 126: 430-439.